. Author manuscript; available in PMC: 2010 Sep 21.

Published in final edited form as: Neurobehav HIV Med. 2010 Aug;2010(2):39–48. doi: 10.2147/NBHIV.S12517

Table 3.

summary of estimated increase in total cholesterol over approximately 12 months for SGA (or risperidone)-exposed versus SGA (or risperidone)-unexposed youth

Model	SGA exposure			Risperidone exposure
	Estimate (mg/dL)	95% confidence interval	P-value	Estimate (mg/dL)	95% confidence interval	P-value
Unadjusted	11.12	(2.21, 20.02)	0.01	13.56	(0.77, 26.35)	0.04
Multivariate model^a	8.68	(0.01, 17.34)	0.0496	13.02	(−0.25, 26.30)	0.055

Notes:

Adjusted for statistically significant covariates (race/ethnicity, primary caregiver, education level of the primary caregiver, limited activity due to health) and covariates chosen a priori as important confounders (4-category ArV use and length of follow-up).

Abbreviation: SGA, second-generation antipsychotic.